Drug Shortage Report for TEVA-PRAVASTATIN

Last updated on 2020-08-21 History
Report ID 94858
Drug Identification Number 02247010
Brand name TEVA-PRAVASTATIN
Common or Proper name PRAVASTATIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-26
Estimated end date 2020-08-31
Actual end date 2020-08-20
Shortage status Resolved
Updated date 2020-08-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-09-26 English Compare
v2 2019-09-26 French Compare
v3 2019-09-27 English Compare
v4 2019-10-24 English Compare
v5 2019-10-24 French Compare
v6 2019-12-05 English Compare
v7 2019-12-05 French Compare
v8 2019-12-12 English Compare
v9 2019-12-12 French Compare
v10 2020-01-09 English Compare
v11 2020-01-09 French Compare
v12 2020-01-24 English Compare
v13 2020-01-24 French Compare
v14 2020-08-20 English Compare
v15 2020-08-20 French Compare
v16 2020-08-21 English Compare

Showing 1 to 16 of 16